Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Self-Care program ease Post-Cancer swelling in the head and neck?

NCT ID NCT06125743

Symptom relief Sponsor: Abramson Cancer Center at Penn Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This study tests whether a structured self-management program can help head and neck cancer survivors cope with lymphedema and fibrosis, which cause swelling and stiffness after treatment. Participants will either follow their usual care or learn the program in person or through telehealth. The goal is to see if the program reduces symptom burden, improves function, and boosts quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured self-management program (LEF-SMP) delivered in-person or via telehealth, compared with usual care.
What this could lead to
If effective, this program could offer head and neck cancer survivors a practical way to reduce swelling and discomfort, improving daily life and quality of life.
What could go wrong
This is a behavioral intervention, so results may vary based on individual adherence. The trial is not a cure and focuses on symptom management, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 204 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \>18 years of age * Post HNC primary treatment * No evidence of cancer (NED) * Completion of initial lymphedema therapy for head and neck lymphedema * Unable to obtain lymphedema therapy due to barriers noted above * History of lymphedema on the face and neck, with or without fibrosis * Ability to understand English in order to complete questionnaires * Ability to perform self-care activities for LEF management * Ability to provide informed consent * Having an electronic device (a computer, tablet, iPad, or smartphone) and internet access at home * A valid email address Exclusion Criteria: * Recurrent or metastatic cancer * Any other active cancer * Acute infection * Acute congestive heart failure * Acute renal failure * Cardiac or pulmonary edema * Sensitive carotid sinus * Severe carotid blockage * Uncontrolled hypertension * Venous thrombosis * Pregnant people * Incarcerated patients

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fibrosis head and neck cancer Head and Neck Neoplasms lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lymphedema of the head and neck

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Barbara Murphy

    RECRUITING

    Nashville, Tennessee, 37232, United States

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.